Currently, due to the limited efficacy of AChE inhibitors as standalone treatments, there is a growing demand for new therapeutic options to address this condition [20] as well as a lack of alternative treatment options for patients with depression [18]. The gene discussed is ACHE; the disease is major depressive disorder.